Newborn Screening in Washington State Saving lives with a simple blood spot

Similar documents
The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Newborn Screening: Focus on Treatment

Positive Newborn Screens: What do you do next?

NEWBORN METABOLIC SCREEN, MINNESOTA

Attachment 1. Newborn Screening Program Description

Saving Lives Through Newborn Screening: Making the Most of a Simple Blood Test

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

Washington State Newborn Screening

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory

For Your Baby s Health Department of Health

Newborn Bloodspot Screening Information for parents

Newborn Bloodspot Screening Information for parents

A Guide for Prenatal Educators

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

Newborn Screening in Manitoba. Information for Health Care Providers

Annual Report Calendar Year 2015

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program. Sara Wolfgram UW Master of Public Health Symposium August 11, 2006

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Health Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE

Newborn Metabolic Screening Programme Annual Report

Screening Newborns for Congenital Disorders

Newborn Screening: Blood Spot Disorders

Annual Report Calendar Year 2014

Information for health professionals

Newborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

Newborn Metabolic Screening Programme. Annual Report

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

What Makes a Satisfactory Newborn Screen Sample?

Newborn Metabolic Screening Programme

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

For the Ongoing Management of Babies under 1 year old.

MI Newborn Screening Program: An Overview of Follow-up & Case Management for Sickle Cell Conditions

SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure

Newborn Screening: Train the Trainer PPT Questions

GUIDE TO NEWBORN SCREENING PROGRAMME

Early Intervention: The Importance of Newborn Screening

Newborn Genetic Testing & Surveillance System

Newborn Screening. Helping babies start life healthy. Minnesota Newborn Screening Program

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Newborn bloodspot testing

Considerations in Choosing Screening Conditions: One (US) Approach

Mississippi Newborn Screening Report

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

Further expansion of the neonatal screening panel in the Netherlands

NEWBORN SCREENING in Massachusetts: Answers for you and your baby

Newborn Screening Manual

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

NEWBORN SCREENING PRENATAL CURRICULUM

Green Amber Red Assurance Level

Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Testing for Genetic Disorders that Cause Brain Damage

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Lab Guide 2019 Metabolic Section Lab Guide

Newborn Screening: What s New?

Newborn Blood Spot Screening Service. Information for Users

Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain.

2015 Annual Report for New Mexico s Newborn Screening (NBS) Program

So Much More Than The PKU Test

Purpose. Newborn Screening- UC 260. What is NBS? What isn t NBS? History. History 2

Health and Wellness for all Arizonans. azdhs.gov

Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M

Annual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017

Information for health professionals

QA/QC 2 Strategies to Reduce False Positives and False Negatives (Part 2)

Institute of Medicine Workshop May 24, 2010 Challenges and Opportunities in Using Newborn Screening Samples for Translational Research

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

Mississippi Newborn Screening Guide for Healthcare Providers

Flow of samples and information for newborn screening in a model of publicprivate

Blood Lead Filter Paper Collection. Regional Pathology Services University of Nebraska Medical Center

Newborn Metabolic Screening Programme. Annual Report

What s new in newborn screening?

Arizona Newborn Screening Program

NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY

Pilot Study of Newborn Screening (NBS) for Inborn Errors of Metabolism (IEM) in Collaboration with Department of Health and Hospital Authority

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

NEWBORN SCREENING FOR SICKLE CELL DISEASE Progress Towards Improved Outcomes for Children and Families

NEWBORN SCREENING IN JAPAN

NATIONAL PROTOCOLS. Newborn Bloodspot Screening Programme. Release: Version 1.0. Date: Feb 2017

Organic Acid Disorders

Sequencing in Newborn Screening Introduction and Background

WHO Growth Grids/ 2012 Risk Changes. Diane Traver Joyce Bryant

UK Newborn Screening for X-ALD - progress from a lab perspective

Screening Division of Public Health Wales NBSW Annual Statistical Report 2017/18

Newborn Metabolic Screening Programme. Annual Report

Standard of Newborn Care in the Age of Birth Plans. Stephanie Deal, MD Tiffany McKee-Garrett, MD

SOP-006 Release to Outside Agency. 2. Procedure for Toxicology Subcontracting (OCME directed)... 3

How MS/MS Revolutionized Newborn Screening

Chapter 26. Newborn Screening

A. Executive Summary:

Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

Inborn Errors of Metabolism (IEM)

WHAT IT MEANS or WHY YOU DO IT

Transcription:

Newborn Screening in Washington State Saving lives with a simple blood spot Ashleigh Ragsdale, MPH Gauri Gupta, MScPH Objectives Newborn Screening Overview Process and Law Completing Collection Cards Video Clip Unsuitable Specimens Q & A What is Newborn Screening? Newborn screening is a public health system that detects infants with serious but treatable conditions that may not be apparent at birth. There are types of newborn screening programs: Blood-spot Blood-spot Hearing Pulse Oximetry Why is Newborn Screening Important? It prevents death and disability for thousands of infants every year in the USA by providing early treatment The public benefits through savings in health care and disability support costs Newborn Screening Goal: Correctly identify babies with congenital disorders and assure that they receive treatment as soon as possible. Each year in Washington State The NBS Program performs approximately : 0 million tests on,000 specimens for 8,000 newborns and we identify: 00 babies every year who benefit from early diagnosis and treatment,00 infants with a hemoglobin trait (not disease) Two year old girls with congenital hypothyroidism

Criteria for Screening A good screening test exists Diagnostic testing and treatment are available Early identification benefits the newborn Nature of the condition justifies population-based screening The benefits justify the costs of screening Washington Screens for... 8 disorders! Immediately Life Threatening Conditions Amino Acid Disorders () Organic Acid Disorders (8) Phenylketonuria (PKU) 8 Isovaleric Acidemia Homocystinuria Glutaric Acidemia type I Maple Syrup Urine Disease Methylmalonic Acidemias (CblA/B and MUT) Citrullinemia type I Propionic Acidemia Argininosuccinic Acidemia Holocarboxylase Synthetase Deficiency Tyrosinemia type I b-ketothiolase Deficiency -hydroxy--methylglutaric aciduria Fatty Acid Oxidation Disorders () Medium-chain Acyl-CoA Dehydrogenase Deficiency Long-chain L--OH Acyl-CoA Dehydrogenase Deficiency Trifunctional Protein Deficiency Very-long-chain Acyl-CoA Dehydrogenase Deficiency Carnitine Uptake Defect Disorders Other Disorders (9) Congenital Hypothyroidism Galactosemia Congenital Adrenal Hyperplasia Biotinidase Deficiency Cystic Fibrosis Sickle Cell Diseases & Hemoglobinopathies Severe Combined Immunodeficiency Amino Acid Disorders () Organic Acid Disorders (8) Phenylketonuria (PKU) Homocystinuria Maple Syrup Urine Disease Citrullinemia type I Argininosuccinic Acidemia Tyrosinemia type I Fatty Acid Oxidation Disorders () Medium-chain Acyl-CoA Dehydrogenase Deficiency Long-chain L--OH Acyl-CoA Dehydrogenase Deficiency Trifunctional Protein Deficiency Very-long-chain Acyl-CoA Dehydrogenase Deficiency Carnitine Uptake Defect Isovaleric Acidemia Glutaric Acidemia type I Methylmalonic Acidemias (CblA/B and MUT) Propionic Acidemia Holocarboxylase Synthetase Deficiency b-ketothiolase Deficiency -hydroxy--methylglutaric aciduria Other Disorders (9) Congenital Hypothyroidism Galactosemia Congenital Adrenal Hyperplasia Biotinidase Deficiency Cystic Fibrosis Sickle Cell Diseases & Hemoglobinopathies Severe Combined Immunodeficiency Specimen Collection: Initial Newborn Screen Each hospital (or health care provider attending an out-of-hospital birth) is required to collect the newborn screening specimen no later than 8 hours following birth (RCW 0.8.00) Collect specimens after 8 hours of age Unless interfering substances are administered Inform parents about the importance of newborn screening Most affected babies appear healthy at birth Fill out screening cards with complete and accurate information Even cards where parents refuse screening Must be received by state lab within hours of collection Note: Parents can legally refuse screening if it conflicts with their religious beliefs.

Specimen Transit The initial blood specimen must be received by the Newborn Screening Laboratory within hours of collection (excluding Sundays and Thanksgiving). (RCW 0.8.00) Dry specimens for hours then send immediately Send each specimen in its own newborn screening envelope To ensure timely receipt, using a courier is recommended Newborn Screening Lab receiving hours: Weekdays: :00 am :00 pm Saturday: 0:00 am :00 pm Holidays: 8:00 am :00 am Closed: Sundays and Thanksgiving Note: Specimens received by 0:00 am on weekdays are tested the same day. Laboratory Processing. Specimen Preparation Specimens sorted, checked for suitability, and accessioned Specimens sorted and checked Laboratory Processing Laboratory Processing. Testing Preparation Eight punches are taken from each specimen for testing the 8 disorders. Specimen Testing A variety of testing platforms are used to screen for the 8 disorders Any abnormal result is repeated in duplicate for confirmation PCR Instrument disorder punch Tandem Mass Spectrometer 9 disorders punch Flouroimmunoassay Instrument disorders punches Specimens are punched Spectrophotometer (Enzyme Activity Assay) disorders punches Hemoglobin Gel Electrophoresis disorders punch

Disorder Follow-Up Reviews abnormal screening results and decides the appropriate follow-up actions for each baby These include: Immediately reporting abnormal results to the health care provider Ensuring a subsequent specimen is submitted to resolve any borderline results Facilitating diagnostic testing when needed Disorder Follow-up also: Assures proper medical care is taken for babies with confirmed diagnoses Tracks abnormal results and confirms diagnoses over time Why Collect a nd Newborn Screen? Not mandated, but standard of care (Ideally collected between & days) The first screen will miss some infants with these disorders, such as milder and later onset forms that may benefit from treatment May be necessary for detection of some conditions and is critical for assessment of cystic fibrosis Verifies hemoglobin traits, eliminating need for diagnostic lab work nd Newborn Screen Collection: Recommended at to days Quality Assurance & Development Tracking & Reporting Send quarterly reports to each hospital about their performance in meeting newborn screening guidelines Specimen Collection and Transit Timing Compliance Specimen Quality Demographic Errors Surveillance Ensure every baby receives a valid newborn screen Education & Outreach Provide technical assistance to health care facilities Create educational materials on newborn screening Promote newborn screening in the community Reporting and Evaluation The Newborn Screening Program will publish an annual report regarding hospitals compliance in meeting the hour transit and 8 hour specimen collection timelines. (RCW 0.8.00) Quality and Compliance Statistics Statewide s July, 0 December, 0 Compliance 9.% On Collection (< 8 hours from birth) 8.0% On Transit (< hours from collection) Reporting and Evaluation The Newborn Screening Program will publish an annual report regarding hospitals compliance in meeting the hour transit and 8 hour specimen collection timelines. (RCW 0.8.00) Quality and Compliance Statistics Statewide s July, 0 December, 0 Compliance 9.% On Collection (< 8 hours from birth) 8.0% On Transit (< hours from collection) Specimen Quality.0% Unsatisfactory specimens.% Demographic errors (cards with one or more errors) Full annual report is available online at www.doh.wa.gov/nbs

back front Washington Collection Card Special Considerations for Premature & Sick Infants Infants who are receiving transfusions, nutritional support (HA/TPN), steroids, antibiotics or are in the intensive or special care nursery CLSI Training Video Clip: 0 0 Collecting a Quality Specimen If possible, collect the first NBS before treatment (even if before 8 hours of age) Except for antibiotics (no need to collect specimen prior to treatment) If collected after treatment, mark the appropriate boxes in the Special Considerations section of collection card HA/TPN: If within hours prior to specimen collection Steroids: If within days prior to specimen collection Antibiotics: If within hours prior to specimen collection RBC Transfusions: Indicate the date of child s last transfusion A third specimen is recommended at - weeks of age for these infants Good Drops, Bad Drops: Unsuitables What is an unsuitable specimen? A specimen that was improperly collected, dried, or transported Types of unsuitable specimens: ABRADED INCSAT DAMAGED LAYERED INSUB-H/A/S/E CONTAMINATED TRANSFUSED TOO OLD PLASTIC Why does suitability matter? Effects the accuracy of test results Causes non-uniform analyte concentrations Falsely elevated or lowered analytes Risks delaying treatment for an affected baby Most Common Unsuitables: Incomplete Saturation or Insufficient Quantity (INCSAT) Problem? Too little blood Solution: Use large drops of blood Piggyback drops within 0 seconds Check for complete saturation after every circle

Most Common Unsuitables: Problem? Solution: Layered/Clotted, or Supersaturated (LAYERED) Too much blood OR Do not re-apply blood after blood on card has begun to clot/dry Apply blood to collection card on one side only Do not over-saturate filter paper by applying too much blood If Having Trouble Collecting a Good Specimen: Try: Hydrating baby before collecting specimen Warming the baby s heel before collecting Gently massaging the leg before heel-stick (makes the blood flow better) Have the baby feed during collection (breast or bottle) Ask parent to hold baby (comfort factor) Keep feet down/swaddle in upright position (gravity works!) Best Practices for st Newborn Screens Collect between 8-8 hours of age Or before interfering substances are administered Specimen is suitable for testing (enough blood, good quality) Dried for three hours Has complete and clear demographic information Includes parental signature if testing refused Mailed same day to us, and arrives at the State Lab within hours of collection Thank you For Making Newborn Screening Successful! Working together we protect the health of Washington s youngest citizens!! Washington State Newborn Screening www.doh.wa.gov/nbs (0) 8-0 or -8-0-900 Ashleigh Ragsdale, MPH Heidi Lovejoy Case Study # Phone call from UW PKU clinic asking about a new referral Check NBS results elevated IRT (screen for cystic fibrosis) Several phone calls later: clinic had called it an abnormal PKU test Crusade to change terminology! We test for 8 disorders now, please call it the: Newborn screen Metabolic panel PKU Test Heel-stick Dried blood spot test

Case Study # Day NBS staff determines st specimen was not collected for baby verifies with birth hospital and requests clinic to collect NBS Day st screen collected Day NBS staff reports abnormal IRT, requests immediate nd specimen Day nd screen collected Day 0 NBS staff recommends DX testing due to abnormal IRT on nd screen Day Baby diagnosed with CF Case Study # Initial hemoglobin results were indicative of transfusion (AA) Results from second NBS were inconsistent with first results (FA) Analyzed all four blood spots obviously blood from two individuals: one baby and one adult Case Study # Continued Initial hemoglobin results were indicative of transfusion (AA) Results from second NBS were inconsistent with first results (FA) Analyzed all four blood spots obviously blood from two individuals: one baby and one adult Baby did not bleed well and phlebotomist supplemented with someone else s blood to fill circles Letter from our Program Director to Hospital Management about this dangerous practice Case Study # Day - Baby born at a local birthing hospital (< miles from NBS lab) NBS specimen collected at h Day - Patient was admitted at tertiary hospital because of high blood ammonia levels Day Received a call from a metabolic specialist inquiring about NBS results - specimen not received in NBS lab Specimens sent via courier to Seattle Children s lab confirming diagnosis of Propionic Acidemia Patient underwent dialysis Day - NBS specimen received, STAT testing revealed elevated C (propionyl carnitine) Day 8 - recovered from metabolic crisis Case Study # Continued We requested that the lab supervisor conduct an investigation regarding the delay Staff in charge of sending NBS specimens was out of the office for days No adequate back-up system was in place, causing batching and courier issues Take home message: ly collection and submission is of utmost importance to prevent death and disability!!!